Tumour characteristics and surgical treatment of renal cell carcinoma in Sweden 2005-2010: a population-based study from the national Swedish kidney cancer register
- PMID: 24666102
- DOI: 10.3109/21681805.2013.864698
Tumour characteristics and surgical treatment of renal cell carcinoma in Sweden 2005-2010: a population-based study from the national Swedish kidney cancer register
Abstract
Objective: Tumour characteristics, preoperative work-up and surgical treatment in patients diagnosed with renal cell carcinoma (RCC) between 2005 and 2010, and changes over time were studied in a national population-based cohort.
Material and methods: The National Swedish Kidney Cancer Register (NSKCR) contains information on histopathology, Fuhrman grade and clinical stage at presentation, and on the preoperative work-up and surgical treatment of patients with RCC. Between 2005 and 2010, 5553 RCC patients were registered in the NSKCR, 99% of those registered in the National Cancer Registry.
Results: During the study period the mean tumour size decreased from 70 to 64 mm (p = 0.024) and the frequency of metastatic RCC decreased from 22% to 15% (p < 0.001). The use of preoperative chest computed tomography increased from 59% to 84%. In total, 4229 (76%) patients were treated with curative intent, 3453 (82%) underwent radical nephrectomy, 606 (14%) partial nephrectomy (PN) and 170 (4%) cryotherapy or radiofrequency ablation. In tumours up to 4 cm, PN was performed in 33% of the surgically treated patients. PN irrespective of size increased from 8% to 20% and laparoscopic nephrectomy increased from 6% to 17% during the period. In patients with metastatic RCC, 55% underwent cytoreductive nephrectomy.
Conclusions: The NSKCR explores population-based data on the clinical handling of patients with RCC. This study, between 2005 and 2010, shows significant decrease in tumour size and metastatic RCC at presentation, a more complete preoperative work-up, and significantly increased use of PN and laparoscopic nephrectomy in Sweden.
Keywords: distant metastasis; lymph-node metastasis; population-based; renal cell carcinoma; survival; tumour category; tumour size.
Similar articles
-
Impact of quality indicators on adherence to National and European guidelines for renal cell carcinoma.Scand J Urol. 2016;50(1):2-8. doi: 10.3109/21681805.2015.1059882. Epub 2015 Jul 23. Scand J Urol. 2016. PMID: 26202573
-
Practice patterns for the surgical treatment of T1 renal cell carcinoma: a nationwide population-based register study.Scand J Urol. 2014 Oct;48(5):445-52. doi: 10.3109/21681805.2014.898686. Epub 2014 Mar 25. Scand J Urol. 2014. PMID: 24666103
-
Metastatic potential in renal cell carcinomas ≤7 cm: Swedish Kidney Cancer Quality Register data.Eur Urol. 2011 Nov;60(5):975-82. doi: 10.1016/j.eururo.2011.06.029. Epub 2011 Jul 1. Eur Urol. 2011. PMID: 21741160
-
Lymph node dissection in renal cell carcinoma.Eur Urol. 2011 Dec;60(6):1212-20. doi: 10.1016/j.eururo.2011.09.003. Epub 2011 Sep 13. Eur Urol. 2011. PMID: 21940096 Review.
-
Management of renal masses in transplant allografts at an Australian kidney-pancreas transplant unit.Transplantation. 2014 Mar 27;97(6):654-9. doi: 10.1097/01.TP.0000437333.38786.fd. Transplantation. 2014. PMID: 24212503 Review.
Cited by
-
HISTOPATHOLOGIC FEATURES OF KIDNEY TUMORS AND COMPARISON OF PATIENTS TREATED WITH RADICAL AND PARTIAL NEPHRECTOMY AT OSIJEK UNIVERSITY HOSPITAL CENTER FROM 2017 UNTIL THE END OF 2021.Acta Clin Croat. 2023 Jul;62(Suppl2):84-94. doi: 10.20471/acc.2023.62.s2.12. Acta Clin Croat. 2023. PMID: 38966018 Free PMC article.
-
Survival in bladder and upper urinary tract cancers in Finland and Sweden through 50 years.PLoS One. 2022 Jan 4;17(1):e0261124. doi: 10.1371/journal.pone.0261124. eCollection 2022. PLoS One. 2022. PMID: 34982793 Free PMC article.
-
DNA methylation status defines clinicopathological parameters including survival for patients with clear cell renal cell carcinoma (ccRCC).Tumour Biol. 2016 Aug;37(8):10219-28. doi: 10.1007/s13277-016-4893-5. Epub 2016 Jan 30. Tumour Biol. 2016. PMID: 26831665
-
The ceRNA Network Has Potential Prognostic Value in Clear Cell Renal Cell Carcinoma: A Study Based on TCGA Database.Biomed Res Int. 2020 Jun 26;2020:4830847. doi: 10.1155/2020/4830847. eCollection 2020. Biomed Res Int. 2020. PMID: 32685491 Free PMC article.
-
A psychometric evaluation of the Functional assessment of cancer therapy-kidney symptom index (FKSI-19) among renal cell carcinoma patients suggesting an alternative two-factor structure.Qual Life Res. 2021 Sep;30(9):2663-2670. doi: 10.1007/s11136-021-02839-9. Epub 2021 Apr 12. Qual Life Res. 2021. PMID: 33846957 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Other Literature Sources
Medical